• Vaxil Locations
  • Contact Us
  • Subscribe
Vaxil Bio
  • About Vaxil
  • TEAM
  • INTELLECTUAL PROPERTY
  • News and Updates
  • In the Media
  • 2025 Shareholder Meeting Material

Category Archives: Annnouncements

05 Aug
Annnouncements

VAXIL ANNOUNCES CHANGES TO SENIOR MANAGEMENT AND PROVIDES UPDATES ON CURRENT RESEARCH AND DEVELOPMENT WORK

… Read the rest
Posted on August 5, 2021 by Gadi Levin
01 Jun
Annnouncements

VAXIL PROVIDES RESEARCH AND DEVELOPMENT UPDATE

… Read the rest
Posted on June 1, 2021 by Gadi Levin
12 Mar
Annnouncements

VAXIL ANNOUNCES 2021 RESEARCH AND DEVELOPMENT STRATEGY AND PROGRESS

… Read the rest
Posted on March 12, 2021 by Gadi Levin
17 Feb
Annnouncements

VAXIL PROVIDES STRATEGY UPDATE FROM CONCLUSION OF COVID-19 CHALLENGE STUDY

… Read the rest
Posted on February 17, 2021 by Gadi Levin
01 Feb
Annnouncements

VAXIL APPOINTS A SPECIAL ADVISOR TO THE BOARD OF DIRECTORS

… Read the rest
Posted on February 1, 2021 by Gadi Levin
Older posts
Newer posts

Vaxil Canada
First Canadian Place, 34th Floor, 100 King Street W., Toronto, Ontario. M2N 6N4 Canada

Vaxil Israel
3 Pinhas Sapir Street, 3rd Floor, Weizmann Science Park, 74140, Rehovot, Israel

Corporate

  • Home
  • About Vaxil
  • Vaxil Locations
  • Contact Us
  • Board & Executives
  • News and Updates

INVESTORS

  • Investor Presentations
  • Public Filings
  • News and Updates
  • In the Media
  • Video
  • Scientific Publications
Copyright 2025 © VAXIL BIO THERAPEUTICS | Vaxil Bio therapeutics is an Israeli biotech focused on cancer immunotherapy, based in the Weizmann Science Park in Rehovot, Israel. Vaxil is listed on the TSX-Venture as VXL
  • About Vaxil
  • TEAM
  • INTELLECTUAL PROPERTY
  • News and Updates
  • In the Media
  • 2025 Shareholder Meeting Material
  • Vaxil Locations
  • Contact Us
  • Subscribe